IDEAYA Biosciences Inc. appointed Dr. Theodora (Theo) Ross, M.D., Ph.D., as Chief Development Officer, a newly created role. Ross will lead early clinical development for the company’s oncology pipeline and help guide long-term R&D strategy. She joins from AbbVie, where she was Vice President, Head of Early Oncology R&D and Bay Area site head.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IDEAYA Biosciences Inc. published the original content used to generate this news brief on February 23, 2026, and is solely responsible for the information contained therein.